19
ScinoPharm Taiwan, Ltd, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A leading process R&D and API Manufacturing service provider to the Global Pharmaceutical Industry.
One of their notable products is FONDAPARINUX SODIUM, with a corresponding application number 208615 and regulatory information .
proudly manufactured in the
approval since 2018-11-14
ScinoPharm Taiwan, Ltd's FONDAPARINUX SODIUM INJECTABLE;SUBCUTANEOUS, medication with 7.5MG/0.6ML of FONDAPARINUX SODIUM.
18
ScinoPharm Taiwan, Ltd, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A leading process R&D and API Manufacturing service provider to the Global Pharmaceutical Industry.
One of their notable products is FONDAPARINUX SODIUM, with a corresponding application number 208615 and regulatory information .
proudly manufactured in the
approval since 2018-11-14
ScinoPharm Taiwan, Ltd's FONDAPARINUX SODIUM INJECTABLE;SUBCUTANEOUS, medication with 2.5MG/0.5ML of FONDAPARINUX SODIUM.
17
ScinoPharm Taiwan, Ltd, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A leading process R&D and API Manufacturing service provider to the Global Pharmaceutical Industry.
One of their notable products is FONDAPARINUX SODIUM, with a corresponding application number 208615 and regulatory information .
proudly manufactured in the
approval since 2018-11-14
ScinoPharm Taiwan, Ltd's FONDAPARINUX SODIUM INJECTABLE;SUBCUTANEOUS, medication with 10MG/0.8ML of FONDAPARINUX SODIUM.
16
ScinoPharm Taiwan, Ltd, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A leading process R&D and API Manufacturing service provider to the Global Pharmaceutical Industry.
One of their notable products is FONDAPARINUX SODIUM, with a corresponding application number 208615 and regulatory information .
proudly manufactured in the
approval since 2018-11-14
ScinoPharm Taiwan, Ltd's FONDAPARINUX SODIUM INJECTABLE;SUBCUTANEOUS, medication with 5MG/0.4ML of FONDAPARINUX SODIUM.